DrugCite
Search

IMPLANON

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Implanon Adverse Events Reported to the FDA Over Time

How are Implanon adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Implanon, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Implanon is flagged as the suspect drug causing the adverse event.

Most Common Implanon Adverse Events Reported to the FDA

What are the most common Implanon adverse events reported to the FDA?

Pregnancy With Implant Contraceptiv...
467 (5.97%)
Abortion Spontaneous
295 (3.77%)
Drug Exposure During Pregnancy
287 (3.67%)
Medical Device Complication
136 (1.74%)
Weight Increased
128 (1.64%)
Headache
123 (1.57%)
Amenorrhoea
119 (1.52%)
Device Dislocation
117 (1.49%)
Vaginal Haemorrhage
109 (1.39%)
Menorrhagia
106 (1.35%)
Depression
92 (1.18%)
Show More Show More
Metrorrhagia
92 (1.18%)
Drug Interaction
90 (1.15%)
Nausea
90 (1.15%)
Menstruation Irregular
82 (1.05%)
Haemorrhage
81 (1.03%)
Device Breakage
79 (1.01%)
Incorrect Drug Administration Durat...
79 (1.01%)
Ectopic Pregnancy
72 (.92%)
Pain In Extremity
72 (.92%)
Dizziness
68 (.87%)
Implant Site Pain
66 (.84%)
Convulsion
63 (.8%)
Weight Decreased
63 (.8%)
Mood Swings
62 (.79%)
No Adverse Event
61 (.78%)
Hypoaesthesia
60 (.77%)
Ovarian Cyst
56 (.72%)
Pain
56 (.72%)
Condition Aggravated
52 (.66%)
Abortion Induced
51 (.65%)
Anaemia
50 (.64%)
Abdominal Pain
49 (.63%)
Complication Of Device Removal
49 (.63%)
Syncope
49 (.63%)
Fatigue
47 (.6%)
Maternal Drugs Affecting Foetus
46 (.59%)
Anxiety
40 (.51%)
Back Pain
39 (.5%)
Loss Of Consciousness
38 (.49%)
Menometrorrhagia
38 (.49%)
Pregnancy
38 (.49%)
Suicidal Ideation
38 (.49%)
Paraesthesia
37 (.47%)
Vomiting
36 (.46%)
Alopecia
35 (.45%)
Migraine
35 (.45%)
Abdominal Pain Upper
33 (.42%)
Breast Cancer Female
33 (.42%)
Dysmenorrhoea
33 (.42%)
Malaise
33 (.42%)
Oedema Peripheral
33 (.42%)
Unintended Pregnancy
33 (.42%)
Drug Ineffective
32 (.41%)
Abortion
30 (.38%)
Pelvic Pain
30 (.38%)
Thrombosis
30 (.38%)
Implant Site Pruritus
28 (.36%)
Breast Cancer
26 (.33%)
Product Quality Issue
26 (.33%)
Acne
25 (.32%)
Epilepsy
25 (.32%)
Pulmonary Embolism
25 (.32%)
Contusion
24 (.31%)
Muscle Spasms
24 (.31%)
Chest Pain
23 (.29%)
Hypothyroidism
23 (.29%)
Implant Site Reaction
22 (.28%)
Cerebrovascular Accident
21 (.27%)
Dyspnoea
21 (.27%)
Infertility Female
21 (.27%)
Swelling Face
20 (.26%)
Urticaria
19 (.24%)
Breast Pain
18 (.23%)
Breast Tenderness
17 (.22%)
Caesarean Section
17 (.22%)
Deep Vein Thrombosis
17 (.22%)
Asthenia
16 (.2%)
Complication Of Device Insertion
16 (.2%)
Hypertension
16 (.2%)
Menstruation Delayed
16 (.2%)
Bipolar Disorder
15 (.19%)
Menstrual Disorder
15 (.19%)
Mood Altered
15 (.19%)
Erythema
14 (.18%)
Implant Site Infection
14 (.18%)
Infection
14 (.18%)
Insomnia
14 (.18%)
Hypersensitivity
13 (.17%)
Implant Site Haematoma
13 (.17%)
Panic Attack
13 (.17%)
Abdominal Pain Lower
12 (.15%)
Arthralgia
12 (.15%)
Fungal Infection
12 (.15%)
Hot Flush
12 (.15%)
Inappropriate Schedule Of Drug Admi...
12 (.15%)
Increased Tendency To Bruise
12 (.15%)
Oestrogen Receptor Assay Positive
12 (.15%)
Pyelonephritis
12 (.15%)
Rash
12 (.15%)
Systemic Lupus Erythematosus
12 (.15%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Implanon, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Implanon is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Implanon

What are the most common Implanon adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Implanon, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Implanon is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Implanon According to Those Reporting Adverse Events

Why are people taking Implanon, according to those reporting adverse events to the FDA?

Contraception
1484
Product Used For Unknown Indication
429
Drug Use For Unknown Indication
227
Drug Exposure During Pregnancy
17
Pregnancy
8
Maternal Exposure During Pregnancy
7
Show More Show More
Maternal Drugs Affecting Foetus
7
Endometriosis
6
Menorrhagia
4
Menstruation Irregular
3
Menstrual Cycle Management
3
Haemorrhage
3
Menstrual Disorder
2
Amenorrhoea
2
Hiv Infection
2
Pain
1
Migraine
1
Dysmenorrhoea
1
Uterine Cancer
1
Maternal Exposure During Delivery
1
Adenomyosis
1
Drug Exposure Via Breast Milk
1
Abdominal Pain
1
Uterine Cyst
1
Prophylaxis
1
Treatment Noncompliance
1
Transdermal Contraception
1

Drug Labels

LabelLabelerEffective
ImplanonOrganon Pharmaceuticals USA13-MAR-12

Implanon Case Reports

What Implanon safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Implanon. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Implanon.